|1.||Rio, Marie-Christine: 3 articles (08/2008 - 09/2003)|
|2.||Stoll, Isabelle: 3 articles (12/2005 - 07/2002)|
|3.||Tuamsuk, Panya: 2 articles (01/2015 - 01/2013)|
|4.||Lu, You-Yong: 2 articles (01/2008 - 01/2005)|
|5.||Li, Wen-Mei: 2 articles (01/2008 - 01/2005)|
|6.||Deng, Hua: 2 articles (01/2008 - 01/2005)|
|7.||Andarawewa, Kumari L: 2 articles (12/2005 - 09/2003)|
|8.||Chenard, Marie-Pierre: 2 articles (12/2005 - 09/2003)|
|9.||Tomasetto, Catherine: 2 articles (12/2005 - 09/2003)|
|10.||Qi, Xin: 1 article (01/2015)|
05/01/2010 - "Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance."
03/01/1998 - "Stromelysin 3 (ST3) is a matrix metalloproteinase implicated in mammary carcinoma progression. "
05/01/1997 - "Stromelysin-3: a paradigm for stroma-derived factors implicated in carcinoma progression."
05/01/1997 - "Epithelial expression of stromelysin 3 predominated in squamous and basaloid carcinomas (P = 0.0005) and was inversely correlated to squamous differentiation (P = 0.018). "
12/20/1996 - "Stromelysin 3 (ST3) is a matrix metalloprotease (MMP) expressed in fibroblast-like cells of most human invasive carcinomas. "
|2.||Stomach Neoplasms (Stomach Cancer)
05/01/2010 - "The aim of this study was to investigate the significance of matrix metalloproteinase 11 expression in gastric cancer. "
05/01/2010 - "Our results demonstrate that matrix metalloproteinase 11 is a novel factor in the development and progression of gastric cancer and suggest that matrix metalloproteinase 11 is a marker for advanced gastric cancer."
05/01/2010 - "Our results show that matrix metalloproteinase 11 expression was significantly higher in gastric cancer specimens compared with nonmalignant tissues at both transcriptional and protein levels, indicating its positive role in the development of gastric cancer. "
05/01/2010 - "Using real-time quantitative reverse-transcription polymerase chain reaction analysis and immunohistochemistry, we studied matrix metalloproteinase 11 expression levels in non-malignant gastric tissues and in gastric cancer tissues. "
01/14/2005 - "Matrix metalloproteinase 11 depletion inhibits cell proliferation in gastric cancer cells."
12/01/2001 - "The purpose of the present comparative immunohistochemical study was to compare rates of cell adhesion molecule (E-cadherin) and protease [stromelysin-3 (ST-3)] expression in groups of de novo (n=64) and ex adenoma (n=42) lesions in order to see whether their more aggressive behavior is associated with decreased cell adhesion and increased protease expression. "
01/01/1999 - "We undertook a series of immunohistochemical (p53, bcl-2, Mib-1, E-cadherin, CD44, Stromelysin-3), and microsatellite analysis studies (on 17p (p53), 18q (DCC), 5q (APC), 8p, 2p and 1p), on groups of de novo and ex adenoma carcinomas in order to see if differences between the two groups of lesions exist. "
01/01/2015 - "Matrix metalloproteinase 11 (MMP11) plays an important role in angiogenesis and changes in its expression level are known to be associated with tumor progression and clinical outcome. "
05/01/2010 - "The association between matrix metalloproteinase 11 expression levels and tumor stage and grade, as well as metastatic potential, was analyzed. "
05/01/2010 - "Matrix metalloproteinase 11 (stromelysin-3) has recently been reported to play a key role in human tumor progression and poor clinical outcome. "
08/01/2008 - "This brief review focuses on the emerging role of matrix metalloproteinase 11 (MMP-11) in cancer progression. "
08/01/2008 - "Cancer cells, adipocytes and matrix metalloproteinase 11: a vicious tumor progression cycle."
|5.||Breast Neoplasms (Breast Cancer)
10/09/1997 - "Modulation of human stromelysin 3 promoter activity and gene expression by human breast cancer cells."
03/01/1993 - "The expression of the stromelysin 3 (ST3) gene, which encodes a putative matrix metalloproteinase, was studied during breast cancer progression. "
07/01/1992 - "The human stromelysin 3 (STMY3) gene, a new member of the matrix metalloproteinase (MMP) gene family, may contribute to breast cancer cell invasion, and has been localized by in situ hybridization to the long arm of chromosome 22. "
03/01/1998 - "Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression."
01/01/2015 - "Gene expression profiling leads to discovery of correlation of matrix metalloproteinase 11 and heparanase 2 in breast cancer progression."
|1.||Matrix Metalloproteinase 11
|3.||Peptide Hydrolases (Proteases)
|4.||Urokinase-Type Plasminogen Activator (Urokinase)
|5.||Matrix Metalloproteinase 2 (Gelatinase A)
|6.||Matrix Metalloproteinase 7 (Matrilysin)
|8.||Cysteine Proteases (Cysteine Protease)
|9.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|1.||Drug Therapy (Chemotherapy)